The FDA approved labeling for sodium oxybate indicates no evidence GHB has teratogenic, carcinogenic or hepatotoxic properties. Its favorable safety profile relative to ethanol might demonstrate why GHB carries on being investigated for a prospect for Liquor substitution.We use this cookie to record data for user account webpages and expert service